Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC

EZH2 is a negative prognostic factor and is overexpressed or activated in most human cancers including head and neck squamous cell carcinoma (HNSCC). Analysis of The Cancer Genome Atlas (TCGA) HNSCC data indicated that EZH2 over-expression was associated with high tumor grade and conferred poor prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Ren, Yu, Kong, Lingping, Cai, Guoshuai, Sun, Shanshan, Song, Wangzhao, Wang, Yu, Jin, Rui, Qi, Lisha, Mei, Mei, Wang, Xudong, Kang, Chunsheng, Li, Min, Zhang, Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741797/
https://www.ncbi.nlm.nih.gov/pubmed/26378043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741797/
https://www.ncbi.nlm.nih.gov/pubmed/26378043

Ejemplares similares